Sign In
Buy RGEN
$149.78
+2.72 (+1.85%)
At Close: Aug 04, 2026
Repligen: Set Recurring Investments To Sleep Well And Help Cure Diseases
10:09am, Tuesday, 03'rd Aug 2021
Repligen is one of those prime companies that let you sleep well at night with a long history of stable performance. The company has shown 30% revenue growth over the past decade, and will lift the tr
Why Repligen Stock Soared This Week
06:11am, Friday, 30'th Jul 2021
The life sciences company reported better-than-expected second-quarter results.
Repligen (RGEN) Beats on Q2 Earnings & Sales, Ups 2021 View
11:25am, Wednesday, 28'th Jul 2021
Repligen (RGEN) reports encouraging second-quarter results, with sales and earnings beating estimates. The company also raises its guidance for 2021.
Repligen Corp, Inc. (RGEN) CEO Anthony Hunt on Q1 2021 Results - Earnings Call Transcript
11:13am, Tuesday, 27'th Jul 2021
Repligen Corp, Inc. (RGEN) CEO Anthony Hunt on Q1 2021 Results - Earnings Call Transcript
Recap: Repligen Q2 Earnings
07:42am, Tuesday, 27'th Jul 2021
Shares of Repligen (NASDAQ:RGEN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 88.10% over the past year to $0.79, whic
Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
07:30am, Tuesday, 27'th Jul 2021
WALTHAM, Mass., July 27, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its s
Earnings Outlook For Repligen
10:37am, Monday, 26'th Jul 2021
Repligen (NASDAQ:RGEN) announces its next round of earnings this Tuesday, July 27. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.
Repligen to Report Second Quarter 2021 Financial Results
07:30am, Tuesday, 13'th Jul 2021
Webcast and Conference Call to Be Held Tuesday, July 27, 2021 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Tuesday, July 27, 2021 at 8:30 a.m. EDT
3 Biotech Stocks Poised to Gain in the Second Half of 2021
09:46am, Tuesday, 06'th Jul 2021
Here we present three biotech companies, which outperformed the sector in the year so far and are likely to witness a winning run in the near term.
Bet on Rising P/E Investing With These Top 5 Stocks
06:01am, Monday, 05'th Jul 2021
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Repligen To Buy Polymem For An Undisclosed Sum
07:20am, Tuesday, 22'nd Jun 2021
Repligen Corporation (NASDAQ: RGEN) has agreed to acquire France-based Polymem S.A., a provider of hollow fiber membranes and modules.
Repligen Corporation Announces Agreement to Acquire Polymem S.A.
06:30am, Tuesday, 22'nd Jun 2021
WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a
RAPT Reports Positive Data From Atopic Dermatitis Study
12:47pm, Wednesday, 16'th Jun 2021
RAPT up on positive data from an early-stage study in patients with moderate-to-severe atopic dermatitis.
Novartis (NVS) & Molecular Partners Initiate Study for COVID-19
03:47pm, Thursday, 27'th May 2021
Novartis (NVS) initiates study for investigating its novel DARPin therapeutic candidate, ensovibep (MP0420), for the treatment of COVID-19, in collaboration with Molecular Partners.
Repligen Corporation to Present at Upcoming Investor Conferences
07:30am, Tuesday, 25'th May 2021
WALTHAM, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virtua
